Anti-Human TL1A/TNFSF15 Reference Antibody|抗人TL1A/TNFSF15参考抗体(靶标：人TL1A（TNFSF15）)
- 货号：RB9THF526016
- 价格：面议
- 点击：445
产品介绍
产品参数
| 形态 | Liquid |
|---|---|
| 宿主种属 | Human |
| 克隆性 | Monoclonal |
| 抗体亚型 | IgG1-kappa |
| 纯度 | >95% purity as determined by SDS-PAGE. |
| 纯化方式 | Protein A/G purified from cell culture supernatant. |
| 浓度 | 4mg/ml |
| 内毒素水平 | Please contact the lab for this information. |
| 应用 | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| 种属反应性 | Human |
| 靶标 | TNFSF15, Vascular endothelial cell growth inhibitor, VEGI, TL1, TNF ligand-related molecule 1, Tumor necrosis factor ligand superfamily member 15 |
| 储存缓冲液 | 0.01M PBS, pH 7.4. |
| 稳定性和储存 | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| 表达系统 | Mammalian Cells |
| 登录号 | O95150 |
| 背景信息 | Duvakitug is a humanized IgG1-λ2 monoclonal antibody targeting to TNFSF15/TL1A. Duvakitug' main expression system is CHOK1SV cells endogenously expressing glutamine synthetase (GS). Duvakitug can be used in the study of Crohn's Disease (CD). • Vascular endothelial growth inhibitor in human cancer (Review)., PMID:19513527 • VEGI-192, a new isoform of TNFSF15, specifically eliminates tumor vascular endothelial cells and suppresses tumor growth., PMID:16061878 |
| 别名 | 2648504-55-4 |
| 备注 | For research use only. Not suitable for clinical or therapeutic use. |
相关产品:
| 产品名称 | 点击数 |
|---|---|
| 氯丙嗪单抗 | 5799 |
| 西马特罗单抗 | 5784 |
| 孕酮单抗 | 5962 |
| 氯霉素（CAP）单抗 | 5895 |
| 红霉素单抗 | 5908 |
| 地克珠利单抗 | 5659 |
| 无色孔雀石绿（LMG）单抗 | 5878 |
| 雌二醇单抗 | 5525 |
| 孔雀石绿（MG）单抗 | 6044 |
| 双酚A单抗 | 5827 |
| 呋喃妥因代谢物（2-NPAHD）单抗 | 5681 |
| 己烯雌酚单抗 | 5716 |
| 莱克多巴胺（RAC）单抗 | 5857 |
| 林可霉素单抗 | 6166 |
| 抗青霉素受体单抗 | 5666 |
| 大观霉素单抗 | 5744 |
| 克伦特罗（CL）单抗 | 5971 |
| 沙拉沙星单抗(2H4) | 5790 |
| 磺胺对甲氧嘧啶（SMD）单抗 | 5939 |
| 磺胺类SAS单抗 | 5865 |
